Read More

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.

AAOI

Read More

Buyer Consortium Led by Recco Control Technology And Dazheng Group Urges The Directors Of Hollysys To Convene The Special Meeting Of Shareholders And The Special Committee To Move Forward With A Transparent And Genuine Sale Process

Buyer consortium ("the consortium") led by Recco Control Technology Pte. Ltd. ("Recco Control Technology") and Dazheng Group (Hong Kong) Investment Holdings Company Limited ("Dazheng Group") expressed its strong desire

HOLI